These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16012011)

  • 61. Evaluation of antimicrobial susceptibility of Enterobacteriaceae causing urinary tract infections in Africa.
    Tansarli GS; Athanasiou S; Falagas ME
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3628-39. PubMed ID: 23689709
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Antibacterial activity of fosfomycin and of the association fosfomycin-rifampicin, upon gram negative bacteria (author's transl)].
    Zemelman R; González C; Mondaca MA
    Rev Med Chil; 1980 Dec; 108(12):1112-7. PubMed ID: 7302408
    [No Abstract]   [Full Text] [Related]  

  • 63. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fosfomycin: use beyond urinary tract and gastrointestinal infections.
    Falagas ME; Giannopoulou KP; Kokolakis GN; Rafailidis PI
    Clin Infect Dis; 2008 Apr; 46(7):1069-77. PubMed ID: 18444827
    [TBL] [Abstract][Full Text] [Related]  

  • 65. First detection of the plasmid-mediated quinolone resistance determinant qnrA in Enterobacteriaceae clinical isolates in Japan.
    Saga T; Akasaka T; Takase H; Tanaka M; Sato K; Kaku M
    Int J Antimicrob Agents; 2007 Jun; 29(6):738-9. PubMed ID: 17374476
    [No Abstract]   [Full Text] [Related]  

  • 66. Treatment of lower urinary tract infections in children: single dose fosfomycin trometamol versus pipemidic acid.
    Careddu P; Borzani M; Scotti L; Varotto F; Garlaschi L; Fontana P
    Chemioterapia; 1987 Aug; 6(4):290-4. PubMed ID: 3652281
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identification of the qnr family in Enterobacteriaceae in clinical practice.
    Naqvi SM; Jenkins C; McHugh TD; Balakrishnan I
    J Antimicrob Chemother; 2009 Apr; 63(4):830-2. PubMed ID: 19218277
    [No Abstract]   [Full Text] [Related]  

  • 68. Mutators among CTX-M beta-lactamase-producing Escherichia coli and risk for the emergence of fosfomycin resistance.
    Ellington MJ; Livermore DM; Pitt TL; Hall LM; Woodford N
    J Antimicrob Chemother; 2006 Oct; 58(4):848-52. PubMed ID: 16891630
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Quinolone resistance in Gram negative rods in Iceland and association with antibiotic use].
    Jónsdóttir K; Kristinsson KG
    Laeknabladid; 2008 Apr; 94(4):279-85. PubMed ID: 18460726
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Lower urinary tract infections: bacterial epidemiology and recommendations].
    Bergogne-Bérézin E
    Prog Urol; 2008 Feb; 18(1 Suppl FMC):F11-4. PubMed ID: 18773847
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Temocillin susceptibility by BSAC methodology.
    Andrews JM; Jevons G; Walker R; Ashby J; Fraise AP
    J Antimicrob Chemother; 2007 Jul; 60(1):185-7. PubMed ID: 17550891
    [No Abstract]   [Full Text] [Related]  

  • 72. [Sensitivity to antibiotics of Escherichia coli strains isolated from children admitted to the "Sf. Ioan" clinical emergency hospital for children in Galaţi during 2005-2006].
    Florea C
    Bacteriol Virusol Parazitol Epidemiol; 2007; 52(1-2):37-44. PubMed ID: 18441957
    [TBL] [Abstract][Full Text] [Related]  

  • 73. qnrA prevalence in extended-spectrum beta-lactamase-positive Enterobacteriaceae isolates from Turkey.
    Oktem IM; Gulay Z; Bicmen M; Gur D;
    Jpn J Infect Dis; 2008 Jan; 61(1):13-7. PubMed ID: 18219128
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Is plasmid-mediated quinolone resistance a clinically significant problem?
    Poirel L; Cattoir V; Nordmann P
    Clin Microbiol Infect; 2008 Apr; 14(4):295-7. PubMed ID: 18190576
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Quinolone resistance in female outpatient urinary tract isolates of Escherichia coli: age-related differences.
    Gobernado M; Valdés L; Alós JI; Garcia-Rey C; Dal-Ré R; García-de-Lomas J;
    Rev Esp Quimioter; 2007 Jun; 20(2):206-10. PubMed ID: 17893757
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Influence of culture media composition on the interpretation of susceptibility tests to fosfomycin].
    Pessione E; Martinetto P; Gaffodio AM; Angeretti A; Giunta C
    G Ital Chemioter; 1979; 26(1-2):195-201. PubMed ID: 400138
    [No Abstract]   [Full Text] [Related]  

  • 77. Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli.
    Gagliotti C; Buttazzi R; Sforza S; Moro ML;
    J Infect; 2008 Sep; 57(3):179-84. PubMed ID: 18707763
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Plasmid-mediated quinolone resistance determinants among enterobacterial isolates from outpatients in Brazil.
    Minarini LA; Poirel L; Cattoir V; Darini AL; Nordmann P
    J Antimicrob Chemother; 2008 Sep; 62(3):474-8. PubMed ID: 18552340
    [TBL] [Abstract][Full Text] [Related]  

  • 79. First detection of plasmid-mediated, quinolone resistance determinants qnrA, qnrB, qnrS and aac(6')-Ib-cr in extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in Budapest, Hungary.
    Szabó D; Kocsis B; Rókusz L; Szentandrássy J; Katona K; Kristóf K; Nagy K
    J Antimicrob Chemother; 2008 Sep; 62(3):630-2. PubMed ID: 18477707
    [No Abstract]   [Full Text] [Related]  

  • 80. Plasmid-mediated quinolone resistance.
    Martínez-Martínez L; Eliecer Cano M; Manuel Rodríguez-Martínez J; Calvo J; Pascual A
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):685-711. PubMed ID: 18847406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.